IO Biotech, Inc. (IOBTQ) Non Operating Income (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Non Operating Income data on file, last reported at $9.3 million in Q3 2025.

• Quarterly Non Operating Income rose 245.18% year-over-year to $9.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.7 million (down 63.0% YoY) and the FY2024 annual result came in at $1.1 million, down 81.83% from the prior year.
• Non Operating Income climbed to $9.3 million in Q3 2025, from -$2.9 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $9.3 million in Q3 2025 to a low of -$29.4 million in Q2 2021.
• A 5-year average of -$594947.4 and a median of $1.2 million in 2024 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2021 — Non Operating Income surged 4626.32% — and 2025, when it plunged 339.89%.
• Tracing IOBTQ's Non Operating Income over 5 years: stood at $154000.0 in 2021, then jumped by 747.4% to $1.3 million in 2022, then surged by 80.38% to $2.4 million in 2023, then tumbled by 267.59% to -$3.9 million in 2024, then surged by 336.07% to $9.3 million in 2025.
• The last three Non Operating Income figures came in at $9.3 million (Q3 2025), -$2.9 million (Q2 2025), and $309000.0 (Q1 2025), per Business Quant data.